tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GLSI Stock Latest News

Greenwich LifeSciences: Strengthened Liquidity and Robust GP2 Data Support Reiterated Buy and $50 Target
RatingsGreenwich LifeSciences: Strengthened Liquidity and Robust GP2 Data Support Reiterated Buy and $50 Target
10d ago
GLSI
Greenwich LifeSciences provides financial update on FLAMINGO-01 Phase 3 trial
PremiumThe Fly
Greenwich LifeSciences provides financial update on FLAMINGO-01 Phase 3 trial
18d ago
GLSI
Greenwich LifeSciences’ GP2 breast cancer therapy approved by FDA
PremiumThe Fly
Greenwich LifeSciences’ GP2 breast cancer therapy approved by FDA
23d ago
GLSI
GLSI-100’s Expanded Efficacy and Market Potential Drive Higher Valuation and Reiterated Buy Rating
PremiumRatings
GLSI-100’s Expanded Efficacy and Market Potential Drive Higher Valuation and Reiterated Buy Rating
2M ago
GLSI
Greenwich LifeSciences price target raised to $50 from $39 at H.C. Wainwright
PremiumThe Fly
Greenwich LifeSciences price target raised to $50 from $39 at H.C. Wainwright
2M ago
GLSI
Greenwich LifeSciences extends lock-up of directors, officers to September 30
PremiumThe FlyGreenwich LifeSciences extends lock-up of directors, officers to September 30
2M ago
GLSI
Greenwich LifeSciences says burn rate for 2025 $7M through first three quarters
Premium
The Fly
Greenwich LifeSciences says burn rate for 2025 $7M through first three quarters
2M ago
GLSI
Greenwich LifeSciences provides update on FLAMINGO-01 trial
Premium
The Fly
Greenwich LifeSciences provides update on FLAMINGO-01 trial
2M ago
GLSI
Greenwich LifeSciences Stockholders Reelect Board and Auditor
PremiumCompany Announcements
Greenwich LifeSciences Stockholders Reelect Board and Auditor
2M ago
8K
GLSI
Greenwich announces 80% recurrence rate reduction in FLAMINGO-01 arm
PremiumThe Fly
Greenwich announces 80% recurrence rate reduction in FLAMINGO-01 arm
2M ago
GLSI
Greenwich LifeSciences: Enrollment complete in open label arm oFLAMINGO-01 trial
PremiumThe Fly
Greenwich LifeSciences: Enrollment complete in open label arm oFLAMINGO-01 trial
2M ago
GLSI
Greenwich LifeSciences screens over 1,000 patients in Flamingo-01 cancer trial
PremiumThe Fly
Greenwich LifeSciences screens over 1,000 patients in Flamingo-01 cancer trial
2M ago
GLSI
Greenwich Lifesciences Advances Phase 3 Breast Cancer Study with GLSI-100
PremiumCompany AnnouncementsGreenwich Lifesciences Advances Phase 3 Breast Cancer Study with GLSI-100
4M ago
GLSI
Greenwich LifeSciences adds Austria to Flamingo-01 clinical trial
Premium
The Fly
Greenwich LifeSciences adds Austria to Flamingo-01 clinical trial
4M ago
GLSI
Greenwich LifeSciences expands Flamingo-01 clinical trial to Belgium
Premium
The Fly
Greenwich LifeSciences expands Flamingo-01 clinical trial to Belgium
5M ago
GLSI
Greenwich LifeSciences adds Portugal to Flamingo-01 clinical trial
PremiumThe Fly
Greenwich LifeSciences adds Portugal to Flamingo-01 clinical trial
5M ago
GLSI
Greenwich LifeSciences expands Phase 3 Flamingo-01 clinical trial to Ireland
PremiumThe Fly
Greenwich LifeSciences expands Phase 3 Flamingo-01 clinical trial to Ireland
5M ago
GLSI
Greenwich LifeSciences granted Fast Track designation for GLSI-100 by FDA
PremiumThe Fly
Greenwich LifeSciences granted Fast Track designation for GLSI-100 by FDA
5M ago
GLSI
Greenwich LifeSciences initiated with an Outperform at Noble Capital
PremiumThe Fly
Greenwich LifeSciences initiated with an Outperform at Noble Capital
6M ago
GLSI
Greenwich LifeSciences to build out internal clinical trial operations team
PremiumThe FlyGreenwich LifeSciences to build out internal clinical trial operations team
6M ago
GLSI
Greenwich LifeSciences announces expansion of Flamingo-01 into Romania
Premium
The Fly
Greenwich LifeSciences announces expansion of Flamingo-01 into Romania
6M ago
GLSI
Greenwich LifeSciences Delays Q1 2025 Report Filing
Premium
Company Announcements
Greenwich LifeSciences Delays Q1 2025 Report Filing
9M ago
GLSI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >